Wells Fargo & Company Issues Positive Forecast for Smartstop Self Storage REIT (NYSE:SMA) Stock Price

by · The Cerbat Gem

Smartstop Self Storage REIT (NYSE:SMA – Get Free Report) had its target price lifted by research analysts at Wells Fargo & Company from $30.00 to $32.00 in a report released on Monday,Benzinga reports. The brokerage currently has an “equal weight” rating on the healthcare company’s stock. Wells Fargo & Company‘s target price indicates a potential upside of 4.15% from the company’s previous close.

Several other equities research analysts also recently issued reports on the stock. Robert W. Baird dropped their price target on shares of Smartstop Self Storage REIT from $37.00 to $36.00 and set an “outperform” rating on the stock in a research note on Wednesday, March 11th. JPMorgan Chase & Co. decreased their price objective on shares of Smartstop Self Storage REIT from $35.00 to $32.00 and set an “underweight” rating for the company in a report on Monday, March 23rd. Zacks Research raised shares of Smartstop Self Storage REIT from a “strong sell” rating to a “hold” rating in a report on Friday, May 8th. Scotiabank raised shares of Smartstop Self Storage REIT to a “strong-buy” rating in a report on Thursday, March 19th. Finally, Weiss Ratings raised shares of Smartstop Self Storage REIT from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, May 11th. Two analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $37.17.

Get Our Latest Stock Analysis on Smartstop Self Storage REIT

Smartstop Self Storage REIT Stock Down 1.7%

Smartstop Self Storage REIT stock traded down $0.53 during midday trading on Monday, hitting $30.73. 83,213 shares of the stock were exchanged, compared to its average volume of 826,431. Smartstop Self Storage REIT has a 1 year low of $29.41 and a 1 year high of $39.77. The firm has a market cap of $1.70 billion, a P/E ratio of 204.77 and a beta of 0.69. The company has a debt-to-equity ratio of 0.86, a current ratio of 5.33 and a quick ratio of 5.33. The company has a 50 day moving average price of $31.33 and a two-hundred day moving average price of $31.97.

Smartstop Self Storage REIT (NYSE:SMA – Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The healthcare company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.01. Smartstop Self Storage REIT had a net margin of 4.38% and a return on equity of 1.00%. The firm had revenue of $78.31 million for the quarter, compared to the consensus estimate of $72.56 million. The company’s revenue for the quarter was up 19.7% compared to the same quarter last year. Smartstop Self Storage REIT has set its FY 2026 guidance at 1.940-2.040 EPS. On average, sell-side analysts predict that Smartstop Self Storage REIT will post 2.02 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of Smartstop Self Storage REIT in the 3rd quarter valued at about $26,000. Creative Financial Designs Inc. ADV acquired a new position in shares of Smartstop Self Storage REIT in the 4th quarter valued at about $25,000. Beacon Capital Management Inc. acquired a new position in shares of Smartstop Self Storage REIT in the 4th quarter valued at about $26,000. Northwestern Mutual Wealth Management Co. acquired a new position in shares of Smartstop Self Storage REIT in the 4th quarter valued at about $27,000. Finally, Raymond James Financial Inc. acquired a new position in shares of Smartstop Self Storage REIT in the 2nd quarter valued at about $35,000.

Smartstop Self Storage REIT Company Profile

(Get Free Report)

Symmetry Medical Inc (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). It also manufactures specialized non-healthcare products, primarily in the aerospace industry.

Recommended Stories